Effect of Vitamins A, C, and E Supplementation in the Treatment of Metabolic Syndrome in Albino Rats

Table 3

Effect of antioxidant supplementation on antioxidant indices and lipid peroxidation.

Group	Vitamin C	Vitamin E	TAS	MDA
	(mg/dL)	(mg/dL)	(mmol/L)	(nmoL/mg tissue)
I	0.95 ± 0.15	0.73 ± 0.32	1.64 ± 0.24	0.382 ± 0.04
II	0.51 ± 0.05^c	0.47 ± 0.01	0.70 ± 0.17^c	1.210 ± 0.22^c
III	0.74 ± 0.17^b,d	0.63 ± 0.06	1.33 ± 0.27^a	0.402 ± 0.08^a
IV	0.66 ± 0.03^c	0.63 ± 0.05	1.16 ± 0.22^b,d	0.425 ± 0.22^a
V	0.74 ± 0.08^b	0.77 ± 0.15^b	1.33 ± 0.28^a	0.423 ± 0.10^a
VI	0.81 ± 0.17^a	0.78 ± 0.12^b	1.42 ± 0.34^a	0.432 ± 0.06^a

TAS-total antioxidant status, MDA-malondialdehyde, I: normotensive control, II: hypertensive control, III: group treated with vit C, IV: group treated with vit A, V: group treated with vit E, and VI: group treated with all the vitamins. Values are expressed as mean ± SD; 𝑛=5. ^aP < 0.01 when compared with group II, ^bP < 0.05 when compared with group II, ^cP < 0.01 when compared with group I, and ^dP < 0.05 when compared with group I by Dunnette’s multiple comparison test.